AIOMEGA LLC Press Releases - EIN Presswire - Press Release Distribution Service

Published on October 19, 2026 - 09:06 GMT

AIOMEGA Founder Highlights Expanding U.S. Patent Portfolio for Dynamic and Responsive Oral-Airway Technologies

Ghuge inventions span physical-activity oral airway technology, biometric tracking, controllers, a longer-term vision of intelligent oral-device systems TYLER, TX, UNITED STATES, October 19, 2026 /⁨EINPresswire.com⁩/ -- AIOMEGA founder and inventor …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...

Published on October 19, 2026 - 04:27 GMT

AIOMEGA Announces Three Australian Patents in Oral-Airway Technology and intelligent Physical-Activity Applications

3 Patents advance AI-robotic maxillary-mandibular airflow improvement during physical activity, lays a foundation for sensor-enabled adaptive oral-devices TYLER, TX, UNITED STATES, October 18, 2026 /⁨EINPresswire.com⁩/ -- AIOMEGA founder and inventor …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on October 1, 2026 - 10:09 GMT

AIOMEGA Announces National Breathe Academy to Train Clinicians in FDA Cleared Adult and Pediatric OSA Treatment Pathways

Clinician training program supports FDA‑cleared adult and pediatric AIO Breathe devices, including prescriptive PLL and growth‑responsive replacement program TYLER, TX, UNITED STATES, October 1, 2026 /⁨EINPresswire.com⁩/ -- AIOMEGA LLC announced the …

Distribution channels: Education, Environment ...

Published on September 21, 2026 - 12:45 GMT

AIOMEGA® Introduces Pediatric Prescribing Precision and AIO Breathe Academy™ for Clinicians Treating Children Ages 6–17

Pediatric OSA clinicians document posterior‑leaning flange angles within the FDA‑cleared AIO Breathe design, supported by AIOMEGA’s clinician training Academy™. TYLER, TX, UNITED STATES, September 21, 2026 /⁨EINPresswire.com⁩/ -- AIOMEGA®, a Texas …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on September 18, 2026 - 19:53 GMT

AIOMEGA® Expands Prescribing Precision for the AIO Breathe® Posterior-Leaning Flange Angle

Clinicians may document an angle greater than 90 degrees within the device’s existing FDA-cleared posterior-leaning flange design. TYLER, TX, UNITED STATES, September 18, 2026 /⁨EINPresswire.com⁩/ -- AIOMEGA®, a Texas biomedical company, announced that …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on May 18, 2026 - 05:57 GMT

AIOMEGA's Pediatric and Adult AIO Breathe® to feature AAVOAT™ and TAVMLR® Mechanistic Insights at SLEEP 2026 Baltimore

New pediatric and adult AIO Breathe® results describe airway changes and AAVOAT™‑TAVMLR® mechanistic insights from observational data presented at SLEEP 2026. TYLER, TX, UNITED STATES, May 18, 2026 /⁨EINPresswire.com⁩/ -- AIOMEGA® Announces Comprehensive …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on April 15, 2026 - 12:25 GMT

Leading Sleep Medicine Organizations Accept Pediatric-Focused Scientific Presentations Featuring AIO Breathe® Platform

Accepted 2026 presentations highlight clinical experience with AIO Breathe® oral appliance therapy in 6-17-year-old children with obstructive sleep apnea TYLER, TX, UNITED STATES, April 15, 2026 /⁨EINPresswire.com⁩/ -- AIOMEGA® today announced that …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on April 10, 2026 - 13:21 GMT

AIOMEGA® to Publish and Present Six Studies at AADSM, AASM, SSS on AIO Breathe® Adult and Pediatric Airway Therapy

Showcasing AAVOAT, TAVMLR® Technology, and Pediatric Growth-Conscious Airway Treatment — Aided by Robotic Precision Execution of AIO AI-Defined Algorithms TYLER, TX, UNITED STATES, April 10, 2026 /⁨EINPresswire.com⁩/ -- AIOMEGA® and the Sleep Medicine …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on February 3, 2026 - 12:49 GMT

AIOMEGA’s AIO Breathe®: First prescribed clinical use of an FDA-cleared mandibular repositioning device in pediatric OSA

AIOMEGA® announced the first prescribed clinical use of AIO BREATHE® mandibular repositioning device, FDA-cleared for pediatric obstructive sleep apnea (OSA). TYLER, TX, UNITED STATES, February 3, 2026 /⁨EINPresswire.com⁩/ -- AIOMEGA® today announced the …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on November 10, 2025 - 15:26 GMT

AIOMEGA® 's AIO Breathe® for children Receives FDA Clearance—Expanding Innovative Sleep Apnea Treatment to pediatrics

AIO Breathe® for children and adolescents with mild to moderate obstructive sleep apnea features identical design and engineering as the adult device. TYLER, TX, UNITED STATES, November 10, 2025 /⁨EINPresswire.com⁩/ -- AIOMEGA® Receives Pediatric …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...